Conatus Pharmaceuticals (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Trading Halts

Roth Capital Reiterates Buy Following Conatus Pharmaceuticals (CNAT) Phase II Emricasan Data January 6, 2016 9:26 AM Conatus Pharmaceuticals (CNAT) Resumes Trading; Shares Up 10%January 5, 2016 4:38 PM Conatus Pharmaceuticals (CNAT) Emricasan Phase 2 Liver Cirrhosis Trial Shows Statistically Significant Reduction in cCK18January 5, 2016 4:07 PM Conatus Achieves Positive Results with Emricasan in Initial Stage of Phase 2 Liver Cirrhosis Clinical TrialJanuary 5, 2016 4:05 PM